TrialMovement disorders : official journal of the Movement Disorder Society2022

Safety and Efficacy of Mevidalen in Lewy Body Dementia: A Phase 2, Randomized, Placebo-Controlled Trial.

Kevin Biglan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.